Top-Rated StocksTop-RatedNASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free IRTC Stock Alerts $116.43 +0.09 (+0.08%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$115.80▼$118.4350-Day Range$102.09▼$120.5252-Week Range$70.24▼$138.64Volume330,725 shsAverage Volume424,391 shsMarket Capitalization$3.62 billionP/E RatioN/ADividend YieldN/APrice Target$135.11 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get iRhythm Technologies alerts: Email Address iRhythm Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside16.0% Upside$135.11 Price TargetShort InterestBearish8.19% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.93Based on 2 Articles This WeekInsider TradingSelling Shares$4.27 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($3.14) to ($1.98) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.57 out of 5 starsMedical Sector854th out of 907 stocksSurgical & Medical Instruments Industry90th out of 97 stocks 2.5 Analyst's Opinion Consensus RatingiRhythm Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageiRhythm Technologies has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.19% of the outstanding shares of iRhythm Technologies have been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 3.24%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRTC. Previous Next 2.2 News and Social Media Coverage News SentimentiRhythm Technologies has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for IRTC on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -83% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,274,942.00 in company stock.Percentage Held by InsidersOnly 0.68% of the stock of iRhythm Technologies is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($3.14) to ($1.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -28.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -28.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 17.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About iRhythm Technologies Stock (NASDAQ:IRTC)iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More IRTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRTC Stock News HeadlinesApril 23, 2024 | finance.yahoo.comWhat Makes iRhythm Technologies (IRTC) a Lucrative Investment?April 18, 2024 | globenewswire.comiRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 14, 2024 | americanbankingnews.comiRhythm Technologies, Inc. (NASDAQ:IRTC) Given Consensus Rating of "Buy" by BrokeragesApril 8, 2024 | markets.businessinsider.com24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythmApril 8, 2024 | investing.comIRTC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action “ IRTCApril 8, 2024 | businesswire.comIRTC DEADLINE TODAY: ROSEN, A RANKED AND LEADING FIRM, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action – IRTCApril 8, 2024 | prnewswire.comShareholders that lost money on iRhythm Technologies, Inc.(IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 6, 2024 | morningstar.comLost Money on iRhythm Technologies, Inc. (IRTC)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyApril 6, 2024 | markets.businessinsider.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythmApril 5, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iRhythm Technologies, Inc. (IRTC)April 5, 2024 | finance.yahoo.comLoss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-TermApril 5, 2024 | prnewswire.comInvestors who lost money on iRhythm Technologies, Inc.(IRTC) should contact The Gross Law Firm about pending Class Action - IRTCApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTCApril 2, 2024 | stockhouse.comINVESTOR DEADLINE MONDAY: iRhythm Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - IRTCApril 2, 2024 | prnewswire.comiRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - IRTCApril 1, 2024 | prnewswire.comiRhythm Technologies, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - IRTCMarch 30, 2024 | prnewswire.comIRTC DEADLINE NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages iRhythm Technologies, Inc. Investors to Secure Counsel Before Important April 8 Deadline in Securities Class Action - IRTCMarch 29, 2024 | prnewswire.comIRHYTHM SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against iRhythm Technologies, Inc. - IRTCMarch 29, 2024 | prnewswire.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythmMarch 29, 2024 | prnewswire.comClass Action Filed Against iRhythm Technologies, Inc. (IRTC) Seeking Recovery for Investors - Contact The Gross Law FirmMarch 28, 2024 | stockhouse.comIMMINENT IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit!March 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against iRhythm Technologies, Inc. - IRTCMarch 27, 2024 | stockhouse.comONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythmMarch 27, 2024 | prnewswire.comShareholders that lost money on iRhythm Technologies, Inc. (IRTC) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreMarch 26, 2024 | prnewswire.comThe Gross Law Firm Notifies iRhythm Technologies, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - IRTCSee More Headlines Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today4/24/2024Next Earnings (Confirmed)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:IRTC CUSIPN/A CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,000Year FoundedN/APrice Target and Rating Average Stock Price Target$135.11 High Stock Price Target$165.00 Low Stock Price Target$110.00 Potential Upside/Downside+15.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($4.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-25.05% Pretax Margin-24.90% Return on Equity-56.38% Return on Assets-28.63% Debt Debt-to-Equity Ratio0.17 Current Ratio2.15 Quick Ratio2.02 Sales & Book Value Annual Sales$492.68 million Price / Sales7.41 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book17.12Miscellaneous Outstanding Shares31,120,000Free Float30,909,000Market Cap$3.65 billion OptionableOptionable Beta1.30 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Quentin S. Blackford (Age 45)President, CEO & Director Comp: $2.15MMr. Brice Bobzien CPA (Age 45)Chief Financial Officer Comp: $685.12kDr. Minang P. Turakhia M.D. (Age 50)M.S., Chief Medical & Scientific Officer and Executive VP of Product Innovation Comp: $1MMr. Patrick Michael Murphy J.D. (Age 45)Chief Business & Legal Officer Comp: $1.28MMr. Douglas J. Devine (Age 54)Executive Advisor Comp: $800kMr. Chad M. Patterson (Age 42)Chief Commercial Officer Comp: $771.51kMr. Marc Rosenbaum (Age 52)Senior VP of Finance & Chief Accounting Officer Mr. Mark J. Day Ph.D. (Age 53)Chief Technology Officer Comp: $718.76kMr. Daniel G. Wilson (Age 41)Executive VP of Corporate Development & Investor Relations Comp: $670.09kMs. Sumi Shrishrimal (Age 45)Executive VP & Chief Risk Officer More ExecutivesKey CompetitorsAxonicsNASDAQ:AXNXHaemoneticsNYSE:HAEMerit Medical SystemsNASDAQ:MMSIPROCEPT BioRoboticsNASDAQ:PRCTICU MedicalNASDAQ:ICUIView All CompetitorsInsiders & InstitutionsAssenagon Asset Management S.A.Bought 919 shares on 4/24/2024Ownership: 0.034%Allspring Global Investments Holdings LLCBought 49,168 shares on 4/18/2024Ownership: 1.334%Diversified Trust CoBought 2,950 shares on 4/18/2024Ownership: 0.016%WoodTrust Financial CorpBought 500 shares on 4/17/2024Ownership: 0.046%CHICAGO TRUST Co NABought 2,145 shares on 4/12/2024Ownership: 0.007%View All Insider TransactionsView All Institutional Transactions IRTC Stock Analysis - Frequently Asked Questions Should I buy or sell iRhythm Technologies stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares. View IRTC analyst ratings or view top-rated stocks. What is iRhythm Technologies' stock price target for 2024? 7 brokers have issued 12-month price targets for iRhythm Technologies' shares. Their IRTC share price targets range from $110.00 to $165.00. On average, they predict the company's stock price to reach $135.11 in the next year. This suggests a possible upside of 16.0% from the stock's current price. View analysts price targets for IRTC or view top-rated stocks among Wall Street analysts. How have IRTC shares performed in 2024? iRhythm Technologies' stock was trading at $107.04 on January 1st, 2024. Since then, IRTC shares have increased by 8.8% and is now trading at $116.43. View the best growth stocks for 2024 here. When is iRhythm Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our IRTC earnings forecast. How can I listen to iRhythm Technologies' earnings call? iRhythm Technologies will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its quarterly earnings data on Thursday, February, 22nd. The company reported ($1.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.66. The company had revenue of $132.51 million for the quarter, compared to analysts' expectations of $131.14 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 56.38% and a negative net margin of 25.05%. What ETFs hold iRhythm Technologies' stock? ETFs with the largest weight of iRhythm Technologies (NASDAQ:IRTC) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Robotics & Automation ETF (ROBO), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), BNY Mellon Innovators ETF (BKIV) and Alger Mid Cap 40 ETF (FRTY). What guidance has iRhythm Technologies issued on next quarter's earnings? iRhythm Technologies updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $575.0 million-$585.0 million, compared to the consensus revenue estimate of $581.1 million. What is Kevin M. King's approval rating as iRhythm Technologies' CEO? 20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA). When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.33%), WoodTrust Financial Corp (0.05%), Assenagon Asset Management S.A. (0.03%), Diversified Trust Co (0.02%), CHICAGO TRUST Co NA (0.01%) and Los Angeles Capital Management LLC (0.01%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IRTC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
